Moderna (NSDQ:MRNA) announced today that Laboratorios Farmacéuticos Rovi has agreed to make Moderna’s COVID-19 vaccine candidate in its Madrid, Spain facility. The contract for large-scale, commercial fill-finish manufacturing in Spain is but the latest that Moderna has secured as it moves forward with Phase 3 of the clinical trial for its COVID-19 vaccine candidate. Moderna in…